Literature DB >> 22124317

Pharmacotherapy: Beneficial effects of evacetrapib.

Bryony M Mearns.   

Abstract

Entities:  

Year:  2011        PMID： 22124317     DOI： 10.1038/nrcardio.2011.193

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Authors:  Stephen J Nicholls; H Bryan Brewer; John J P Kastelein; Kathryn A Krueger; Ming-Dauh Wang; Mingyuan Shao; Bo Hu; Ellen McErlean; Steven E Nissen
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272
  1 in total
  1 in total

Review 1.  HDL and cholesterol: life after the divorce?

Authors:  Kasey C Vickers; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-03-19       Impact factor: 5.922
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.